It might eliminate all infections for all we know. Or, it might simply make infections that would have been symptomatic much milder so that they become asymptomatic and therefore unreported. You don't know, I don't know, nobody knows.
It should be obvious it does not matter whether methylene blue eliminates all infections, or just makes them so mild that they become asymptomatic. In either case, nobody gets a serious infection, and nobody dies. That's basically what you want an antiviral drug to do.
On the 27 March 2020, these 2500 cancer patients were interviewed in the study, and reported no symptoms of coronavirus.
By a calculation I did, in the rest of France on that date, you would expect 30 cases of symptomatic coronavirus infection in any arbitrary group of 2500 people. This figure of 30 was arrived at by using the Tomas Pueyo, plus data from the Diamond Princess.
So very simply, this suggests methylene blue has a protective effect.
I agree that cancer patients may possibly be staying more at home than the general population, and so more protected from the virus. But this may not even be relevant, as France has been in lockdown anyway, so everyone will be staying at home.
I'm out. You clearly are not willing to listen.
I'm listening, but your argument is confused.
And you keep talking about reported cases, but I am not using report case data at all. I am calculating the number infected, and the number of symptomatically infected, starting with the death toll figures, which are far more reliable.
And oh by the way, extrapolating from a cruise ship to a country is bullshit from the get go.
Why? I am only using the Diamond Princess to determine the ratio of symptomatic to a symptomatic. Why should that be different on a cruise ship compared to a country?
Edited by Hip, 09 April 2020 - 04:15 PM.